September 26, 2017
Sanofi-Aventis urged a Massachusetts magistrate judge Tuesday to dismiss an antitrust suit over its Lantus diabetes treatments, arguing that it reasonably listed its products in the so-called Orange Book and that its patent litigation against Eli Lilly was not a sham.